Facebook Inc. took a momentous action last week. And I don’t mean its announced intention to sell shares for $28 to $35 in an initial public offering later this month.

In October of 2009, Kumud Majumder, the father of an 11-year-old son with advanced leukemia, joined a lawsuit challenging the federal ban on compensating bone-marrow donors. He wanted to save his son's life. Last week Mr. Majumder and his co-plaintiffs enjoyed a victory. The U.S. Court of Appeals for the Ninth Circuit ruled that the majority of bone-marrow donors may lawfully be compensated.

A brief analysis of current public opinion on global environment satisfaction, organ donation, and more.

This event will discuss organ donation.

Our nation's current organ donation system relies on altruism alone, but a regime of donor compensation would be better.

Meaningful rewards for living donations could provide the answer to the kidney shortage.